• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN NANOCROSS ELITE 0.14 OTW PTA DILATATION CATHETER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN NANOCROSS ELITE 0.14 OTW PTA DILATATION CATHETER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number AB14W050040150
Device Problem Detachment of Device or Device Component (2907)
Patient Problem Injury (2348)
Event Date 11/02/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Physician intended to use a nanocross elite pta balloon with a non-medtronic 7fr sheath and non-medtronic guidewire during treatment of a 40mm plaque lesion in the patient¿s proximal left superficial femoral artery (sfa).Artery diameter reported as 9mm.Slight vessel calcification and tortuosity are reported.No damage was noted to the product packaging prior to sue.No issues were noted when removing the device from the packaging.Ifu was followed and the device was prepped without issue.Following use of the balloon, it is reported that excessive force was used during withdrawal of the device as the physician felt resistance at the sheath and tugged.This resulted in a detachment at the tip with part of the balloon remaining in the sheath.The fragment dislodged at the access site as everything was removed.Access was gained on the opposite side and a snare was used for removal of the detached portion.No further injury reported.
 
Manufacturer Narrative
Device evaluation the nanocross elite catheter was received in two segments.The proximal segment consisting of the y-manifold, catheter, and inner guidewire lumen.The distal segment consisting of the balloon chamber and distal tip.An inventory of the nanocross elite components revealed that the two radiopaque marker bands were not returned with the device.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NANOCROSS ELITE 0.14 OTW PTA DILATATION CATHETER
Type of Device
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
MDR Report Key10815678
MDR Text Key215470520
Report Number2183870-2020-00379
Device Sequence Number1
Product Code LIT
UDI-Device Identifier00763000110246
UDI-Public00763000110246
Combination Product (y/n)N
PMA/PMN Number
K132777
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 03/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/17/2023
Device Model NumberAB14W050040150
Device Catalogue NumberAB14W050040150
Device Lot NumberB071112
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/20/2020
Date Manufacturer Received03/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-